Skip to content
Recall Observatory FDA recall evidence

Drug product

Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01

D-0573-2022

February 07, 2022

Class II

Product summary

Firm
RISING PHARMACEUTICALS
Event
Event 89545
Status
Ongoing
Classification
Class II
Quantity
2220 100-count bottles
Official record key
drug-enforcement:D-0573-2022

Official wording

Reason: Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.

Code information: lot# 25910009, Exp 01/2023

Distribution pattern: Nationwide in the USA

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.

Field note

Send feedback

We'll only use this to respond to your feedback.